Attovia Therapeutics, Inc. (ATTO)
13.83
-0.67
(-4.62%)
USD |
NASDAQ |
Oct 23, 16:00
13.83
0.00 (0.00%)
After-Hours: 20:00
Attovia Therapeutics Market Cap : 631.36M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 631.36M |
| October 22, 2026 | 661.94M |
| October 21, 2026 | 647.34M |
| October 20, 2026 | 640.94M |
| October 19, 2026 | 634.10M |
| October 16, 2026 | 626.79M |
| October 15, 2026 | 674.73M |
| October 14, 2026 | 682.94M |
| October 13, 2026 | 671.99M |
| October 12, 2026 | 666.05M |
| October 09, 2026 | 740.01M |
| October 08, 2026 | 744.57M |
| October 07, 2026 | 749.59M |
| October 06, 2026 | 798.90M |
| October 05, 2026 | 821.50M |
| October 02, 2026 | 783.83M |
| October 01, 2026 | 812.14M |
| September 30, 2026 | 782.46M |
| September 29, 2026 | 829.03M |
| September 28, 2026 | 805.75M |
| September 25, 2026 | 811.68M |
| September 24, 2026 | 829.48M |
| September 23, 2026 | 845.46M |
| September 22, 2026 | 950.92M |
| September 21, 2026 | 972.37M |
| Date | Value |
|---|---|
| September 18, 2026 | 1.011B |
| September 17, 2026 | 1.038B |
| September 16, 2026 | 1.016B |
| September 15, 2026 | 1.082B |
| September 14, 2026 | 1.119B |
| September 11, 2026 | 1.040B |
| September 10, 2026 | 1.029B |
| September 09, 2026 | 1.044B |
| September 08, 2026 | 1.080B |
| September 04, 2026 | 1.166B |
| September 03, 2026 | 1.105B |
| September 02, 2026 | 1.056B |
| September 01, 2026 | 1.014B |
| August 31, 2026 | 976.94M |
| August 28, 2026 | 944.98M |
| August 27, 2026 | 923.40M |
| August 26, 2026 | 841.22M |
| August 25, 2026 | 830.89M |
| August 24, 2026 | 887.26M |
| August 21, 2026 | 895.00M |
| August 20, 2026 | 869.62M |
| August 19, 2026 | 952.66M |
| August 18, 2026 | 999.99M |
| August 17, 2026 | 977.19M |
| August 14, 2026 | 854.56M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Agenus, Inc. | 269.76M |
| Amgen, Inc. | 237.46B |
| Anika Therapeutics, Inc. | 286.66M |
| BioCryst Pharmaceuticals, Inc. | 1.953B |
Market Cap Related Metrics
| PS Ratio | 1403.02 |
| Price | 13.83 |
| Earnings Yield | -10.96% |